聚维酮碘1%是预防剖宫产术后子宫内膜炎最有效的阴道消毒剂:系统评价与网状Meta分析
本系统评价与网状Meta分析纳入23项随机临床试验共7097名剖宫产患者,比较不同阴道消毒制剂预防子宫内膜炎的效果。结果显示,与生理盐水或不处理相比,所有消毒制剂均降低子宫内膜炎发生率(5.2% vs 9.1%;OR 0.48;95%CI 0.35-0.65),其中聚维酮碘1%成为最有效治疗的概率最高(72.7%),且聚维酮碘显著降低伤口感染和发热风险。
要点
- 与生理盐水或不处理相比,剖宫产术前阴道消毒制剂降低子宫内膜炎发生率(5.2% vs 9.1%;OR 0.48;95%CI 0.35-0.65)。
- 聚维酮碘1%在预防子宫内膜炎方面成为最有效治疗的概率最高(72.7%)。
- 聚维酮碘显著降低术后伤口感染(OR 0.61;95%CI 0.48-0.78)和发热(OR 0.58;95%CI 0.40-0.83)。
核心结论
- 剖宫产患者术前阴道冲洗使用聚维酮碘在降低子宫内膜炎、术后伤口感染和发热风险方面概率最高。
研究设计与样本
- 系统评价与网状Meta分析,检索MEDLINE、EMBASE(从建库至2018年11月)和Cochrane数据库、传记和会议论文集。
- 纳入剖宫产术前使用消毒制剂进行阴道准备以降低感染风险的随机临床试验。
- 共纳入23项研究,包含7097名女性,分配至聚维酮碘(1%、5%、10%)、氯己定(0.2%、0.4%)、甲硝唑凝胶、西曲溴铵、生理盐水或不处理组。
- 采用多变量随机效应模型和Meta回归进行直接与间接成对比较,使用频率学派推断方法估计排序概率。
主要发现
- 与生理盐水或不处理相比,所有消毒制剂降低子宫内膜炎发生率(5.2% vs 9.1%;OR 0.48;95%CI 0.35-0.65;22项研究/6994名女性)。
- 聚维酮碘显著降低子宫内膜炎风险(OR 0.43;95%CI 0.28-0.64;16项研究/5968名女性)。
- 西曲溴铵显著降低子宫内膜炎风险(OR 0.34;95%CI 0.13-0.90;1项研究/200名女性)。
- 甲硝唑显著降低子宫内膜炎风险(OR 0.38;95%CI 0.16-0.90;1项研究/224名女性)。
- 聚维酮碘1%成为预防子宫内膜炎最有效治疗的概率最高(72.7%)。
关键数值与推荐
- 聚维酮碘显著降低术后伤口感染(OR 0.61;95%CI 0.48-0.78;16项研究/5968名女性)和发热(OR 0.58;95%CI 0.40-0.83;12项研究/4667名女性)。
- 聚维酮碘显著降低临产女性子宫内膜炎风险(OR 0.42;95%CI 0.20-0.88;5项研究/1211名女性)。
- 聚维酮碘显著降低胎膜已破女性子宫内膜炎风险(OR 0.21;95%CI 0.10-0.44;4项研究/476名女性)。
- 聚维酮碘显著降低计划性剖宫产女性子宫内膜炎风险(OR 0.39;95%CI 0.27-0.57;8项研究/1825名女性)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Direct comparison metaanalyses have reported benefits with presurgical vaginal preparation before cesarean delivery for the reduction of endometritis. These reports did not perform a multitreatment comparison of the various antiseptic solutions assessed in previous studies. OBJECTIVE: The purpose of this study was to review the literature systematically and quantitate and summarize indirectly the comparative efficacy of antiseptic formulations and their concentrations that are used for the preparation of the vagina before cesarean delivery in the prevention of endometritis and other infectious complications. STUDY DESIGN: We used MEDLINE, EMBASE (from their inception to November 2018) and Cochrane databases, biographies, and conference proceedings. We used randomized clinical trials of patients who underwent surgical preparation of the vagina with antiseptic formulations before cesarean delivery with the aim of reducing the risk of infectious morbidity. Our systematic review was registered and followed the Preferred Reporting Items for Systematic Review and Meta-analysis Extension for network meta-analysis guidelines. Network meta-analysis was performed with computerized software and used user-written programs to assess consistency, inconsistency, ranking probabilities, and graphing results. Direct and indirect pairwise comparisons of the various formulations and their concentrations were performed with the use of multivariate random-effects models and metaregression. A frequentist inference method was employed for the fitted model to estimate the ranking probabilities. Subgroup analyses for patients in labor, not in labor, and with ruptured membranes were conducted. RESULTS: For the prevention of endometritis, we identified 23 studies that comprised 7097 women who were allocated to the following treatments: povidone-iodine (1%, 5%, 10%), chlorhexidine (0.2%, 0.4%), metronidazole gel, cetrimide, or normal saline solution/no treatment. Direct and indirect pairwise comparisons indicated that, when compared with saline solution or no treatment, all antiseptic formulations decreased rates of endometritis (5.2% vs 9.1%; odds ratio, 0.48; 95% confidence interval, 0.35-0.65; 22 studies/6994 women). Individually, povidone-iodine (odds ratio, 0.43; 95% confidence interval, 0.28-0.64; 16 studies/5968 women), cetrimide (odds ratio, 0.34; 95% confidence interval, 0.13-0.90; 1 study/200 women), and metronidazole (odds ratio, 0.38; 95% confidence interval, 0.16-0.90; 1 study/224 women) significantly reduced the risk of endometritis. Rankings of vaginal preparations indicated that povidone-iodine 1% had the highest probability (72.7%) of being the most effective treatment for the prevention of endometritis. For the secondary outcomes of postoperative wound infection and fever, a significant reduction was found only with povidone-iodine (odds ratio, 0.61; 95% confidence interval, 0.48-0.78; 16 studies/5968 women; and odds ratio, 0.58; 95% confidence interval, 0.40-0.83; 12 studies/4667 women). Subgroup analyses also found that povidone-iodine significantly reduced risk of endometritis for women in labor (odds ratio, 0.42; 95% confidence interval, 0.20-0.88; 5 studies/1211 women), with ruptured membranes(odds ratio, 0.21; 95% confidence interval, 0.10-0.44; 4 studies/476 women), and undergoing planned cesarean delivery (odds ratio, 0.39; 95% confidence interval, 0.27-0.57; 8 studies/1825 women). CONCLUSION: Among patients who underwent cesarean delivery, presurgical vaginal irrigation with povidone-iodine had the highest probability of reducing the risk of endometritis, postoperative wound infections, and fever.
引用
- Roeckner JT, Sanchez-Ramos L, Mitta M, et al. Povidone-iodine 1% is the most effective vaginal antiseptic for preventing post-cesarean endometritis: a systematic review and network meta-analysis. Am J Obstet Gynecol. 2019. PMID: 30954518. doi:10.1016/j.ajog.2019.04.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。